Coherus Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Coherus Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Coherus Biosciences Inc
Rating: 2.60158325
Author: Trendlyne DVM scores

about

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

1.18 0.04 (3.51%)

51.44% Fall from 52W High

895.9K

XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Not Eligible

Mid Valuation

47.3 / 100

Technically Neutral

56.7 / 100

1Yr Price target upside is 298%

3 analysts

Coherus Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coherus Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

51.44% Fall from 52W High

SWOT Analysis

Coherus Biosciences Inc Live Price Chart